HomeCompareEKIVF vs CHD

EKIVF vs CHD: Dividend Comparison 2026

EKIVF yields 3.65% · CHD yields 1.28%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EKIVF wins by $1124.51M in total portfolio value
10 years
EKIVF
EKIVF
● Live price
3.65%
Share price
$1.04
Annual div
$0.04
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1124.54M
Annual income
$1,068,381,722.40
Full EKIVF calculator →
CHD
CHD
● Live price
1.28%
Share price
$93.32
Annual div
$1.19
5Y div CAGR
23.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.4K
Annual income
$1,302.64
Full CHD calculator →

Portfolio growth — EKIVF vs CHD

📍 EKIVF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEKIVFCHD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EKIVF + CHD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EKIVF pays
CHD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EKIVF
Annual income on $10K today (after 15% tax)
$310.65/yr
After 10yr DRIP, annual income (after tax)
$908,124,464.04/yr
CHD
Annual income on $10K today (after 15% tax)
$108.62/yr
After 10yr DRIP, annual income (after tax)
$1,107.24/yr
At 15% tax rate, EKIVF beats the other by $908,123,356.80/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EKIVF + CHD for your $10,000?

EKIVF: 50%CHD: 50%
100% CHD50/50100% EKIVF
Portfolio after 10yr
$562.28M
Annual income
$534,191,512.52/yr
Blended yield
95.00%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CHD right now

EKIVF
No analyst data
Altman Z
2.9
Piotroski
7/9
CHD
Analyst Ratings
18
Buy
15
Hold
1
Sell
Consensus: Buy
Price Target
$98.40
+5.4% upside vs current
Range: $82.00 — $110.00
Altman Z
4.9
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EKIVF buys
0
CHD buys
11
PoliticianChamberTickerTypeAmountDate
Richard W. Allen🏢 House$CHD▼ Sell$15,001 - $50,0002025-10-10
Ro Khanna🏢 House$CHD▲ Buy$1,001 - $15,0002025-09-29
Lisa McClain🏢 House$CHD▼ Sell$1,001 - $15,0002025-09-25
Lisa McClain🏢 House$CHD▲ Buy$1,001 - $15,0002025-08-04
Ro Khanna🏢 House$CHD▲ Buy$1,000 - $15,0002025-08-04
Lisa McClain🏢 House$CHD▼ Sell$1,001 - $15,0002025-06-24
Lisa McClain🏢 House$CHD▲ Buy$1,001 - $15,0002025-06-17
Jonathan Jackson🏢 House$CHD▼ Sell$15,001 - $50,0002025-05-14
Jonathan Jackson🏢 House$CHD▼ Sell$1,001 - $15,0002025-05-05
Jonathan Jackson🏢 House$CHD▲ Buy$1,001 - $15,0002025-04-23
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEKIVFCHD
Forward yield3.65%1.28%
Annual dividend / share$0.04$1.19
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%23.1%
Portfolio after 10y$1124.54M$26.4K
Annual income after 10y$1,068,381,722.40$1,302.64
Total dividends collected$1120.48M$5.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: EKIVF vs CHD ($10,000, DRIP)

YearEKIVF PortfolioEKIVF Income/yrCHD PortfolioCHD Income/yrGap
1← crossover$11,431$730.95$10,857$157.30+$574.00EKIVF
2$13,793$1,561.76$11,814$196.49+$2.0KEKIVF
3$18,281$3,522.36$12,887$245.97+$5.4KEKIVF
4$28,286$8,726.08$14,097$308.68+$14.2KEKIVF
5$55,504$25,237.74$15,473$388.49+$40.0KEKIVF
6$151,954$92,564.47$17,046$490.55+$134.9KEKIVF
7$636,261$473,670.51$18,861$621.76+$617.4KEKIVF
8$4,387,998$3,707,198.50$20,973$791.47+$4.37MEKIVF
9$52,483,610$47,788,452.15$23,454$1,012.51+$52.46MEKIVF
10$1,124,539,185$1,068,381,722.40$26,398$1,302.64+$1124.51MEKIVF

EKIVF vs CHD: Complete Analysis 2026

EKIVFStock

Enka Insaat ve Sanayi A.S., together with its subsidiaries, operates as a construction company in Turkey, Russia, Kazakhstan, Georgia, Iraq, and internationally. It operates through four segments: Construction, Rental, Energy, and Trading and Manufacturing. The company engages in the construction of industrial and social buildings, and motorways; construction and operation of natural gas fired electrical energy generation facilities; and investment in and development of real estate properties and shopping malls. It is also involved in the marketing and after-sale service of construction machineries, trucks, industrial products, and spare parts; manufacturing of structural steel works; installation and establishment of the technical equipment; and excavation backfilling works and quarrying crushing operation of highway projects. In addition, the company engages in the pile dwelling work; base and superstructure construction; slip form and construction of drilling and ground surveys; organization of conventions and seminars; tour reservations and tickets sales; production of ready-mixed concrete; production and sale of electricity; repair and maintenance of power plants; and provision of architectural design and air transportation services, as well as trading activities. Further, it is involved in various activities, such as material handling and storage systems, auxiliary facilities, water treatment and environmental engineering, infrastructure and construction, control systems, and instrumentation engineering activities. Enka Insaat ve Sanayi A.S. was incorporated in 1957 and is headquartered in Istanbul, Turkey.

Full EKIVF Calculator →

CHDConsumer Staples

Church & Dwight Co., Inc. develops, manufactures, and markets household, personal care, and specialty products. It operates through three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; battery-operated and manual toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and replacement showerheads under the WATERPIK brand; FLAWLESS products; cold shortening and relief products under the ZICAM brand; and oral care products under the THERABREATH brand. Its specialty products include animal productivity products, such as MEGALAC rumen bypass fat, a supplement that enables cows to maintain energy levels during the period of high milk production; BIO-CHLOR and FERMENTEN, which are used to reduce health issues associated with calving, as well as provides needed protein; and CELMANAX refined functional carbohydrate, a yeast-based prebiotic. The company offers sodium bicarbonate; and cleaning and deodorizing products. It sells its consumer products through supermarkets, mass merchandisers, wholesale clubs, drugstores, convenience stores, home stores, dollar and other discount stores, pet and other specialty stores, and websites and other e-commerce channels; and specialty products to industrial customers and livestock producers through distributors. The company was founded in 1846 and is headquartered in Ewing, New Jersey.

Full CHD Calculator →
📬

Get this EKIVF vs CHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EKIVF vs SCHDEKIVF vs JEPIEKIVF vs OEKIVF vs KOEKIVF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.